Third Harmonic Bio, Inc. is a biopharmaceutical company. Co. is focused on advancing the next wave of medicine for inflammatory diseases through the development of novel, small-molecule inhibitors of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. It is developing medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. Mast cells are a part of the immune system, and dysfunctional mast cell activity has been implicated in the pathophysiology of a broad range of inflammatory disorders including urticaria, asthma and gastrointestinal disorders, among others. We show 11 historical shares outstanding datapoints in our coverage of THRD's shares outstanding history.
Understanding the changing numbers of THRD shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like THRD versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching THRD by allowing them to research THRD shares outstanding history
as well as any other stock in our coverage universe. |
Free THRD Email Alerts:
Video: Shares Outstanding Importance
